|
Website:
http://www.enzo.com
Phone: +1 212 583-0100 |
Address:
527 Madison Avenue
New York, NEW YORK 10022 |
Company Description
Enzo Biochem, Inc.. The Group's principal activities are the research, development, manufacture and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. It operates in three Segments: Enzo Life Sciences Segment, Enzo Therapeutics Segment and Enzo Clinical Labs Segment. Enzo Life Sciences Segment manufacturers, develops and markets biomedical research products and tools to research and pharmaceutical customers. Enzo Therapeutics Segment conducts research and development activities for therapeutic drug candidates. Enzo Clinical Labs Segment provides diagnostic services to the health care community. The Group operates in the United States. Clinical Labs accounted for 80% of fiscal 2006 revenues and Life Sciences , 20%
Key People
| Chairman & Chief Executive | Dr. Elazar Rabbani |
| President & Chief Financial Officer | Barry W. Weiner |
| Chief Operating Officer, Secretary & Treasurer | Shahram K. Rabbani |
| Vice President Finance | Herbert B. Bass |
Related Business Topics
A-Z Enzo Biochem, Inc. Provider Directory
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
E
Enzo Diagnostics, Inc.
Manufacturer of highly specialized diagnostic biotechnology products. The products use nonradioactive methods for tumor origin indentification and they visualize molecules by using Biotin-Avadin technology to tag enzymes and probe for viruses a...
www.enzo.com
Manufacturer of highly specialized diagnostic biotechnology products. The products use nonradioactive methods for tumor origin indentification and they visualize molecules by using Biotin-Avadin technology to tag enzymes and probe for viruses a...
www.enzo.com
Breaking News
Reuters - Nov. 25, 2009, 4:01 PM
CNBC - Nov. 25, 2009, 3:37 PM
Forbes.com - Nov. 18, 2009, 5:46 AM
CNBC - Nov. 13, 2009, 7:17 AM
More Enzo Biochem News


